Pancreatic Cancer: Novel Immunotherapy Shows Promise
Pancreatic cancer, notoriously one of the deadliest forms of the disease, has historically defied effective treatment. But a confluence of recent clinical trial results suggests a paradigm shift is underway. While the five-year survival rate remains stubbornly low – currently around 11% – the emergence of personalized immunotherapy strategies is injecting a much-needed dose of … Read more